Vilanterol (trifenatate) Catalog No.:M9740-2 T-5224 has been investigated in

T-5224 has been investigated in phase II human clinical trials

InChi: InChI=1S/C10H8O5/c1-6(11)10(14)15-8-5-3-2-4-7(8)9(12)13/h2-5H

8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid

leading to the dose-dependent cell growth inhibition and apoptosis induction in cells without wild-type p53

3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanamido]ethoxy}ethoxy)ethoxy]acetate

Vilanterol (trifenatate) Catalog No.:M9740-2 T-5224 has been investigated inVilanterol, also known as GW 642444, is a long acting beta 2 agonist drug, which in May 2013 was approved in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD). Product information CAS Number: 503070 58 4 Molecular Weight: 774. 77 Formula: C44H49Cl2NO7 Chemical Name: 4 [(1R) 2 [(6 {2 [(2,6 dichlorophenyl)methoxy]ethoxy}hexyl)amino] 1 hydroxyethyl] 2